Katherine E. Fleming-Dutra

11.1k total citations · 8 hit papers
123 papers, 5.3k citations indexed

About

Katherine E. Fleming-Dutra is a scholar working on Epidemiology, Applied Microbiology and Biotechnology and Infectious Diseases. According to data from OpenAlex, Katherine E. Fleming-Dutra has authored 123 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Epidemiology, 43 papers in Applied Microbiology and Biotechnology and 39 papers in Infectious Diseases. Recurrent topics in Katherine E. Fleming-Dutra's work include Pneumonia and Respiratory Infections (43 papers), Antibiotic Use and Resistance (43 papers) and Respiratory viral infections research (23 papers). Katherine E. Fleming-Dutra is often cited by papers focused on Pneumonia and Respiratory Infections (43 papers), Antibiotic Use and Resistance (43 papers) and Respiratory viral infections research (23 papers). Katherine E. Fleming-Dutra collaborates with scholars based in United States, United Kingdom and Australia. Katherine E. Fleming-Dutra's co-authors include Lauri A. Hicks, Rebecca M. Roberts, Adam L. Hersh, Guillermo V. Sanchez, Tamara Pilishvili, Laura King, Amadea Britton, Ryan Gierke, Michelle M. Hughes and Emily N. Ussery and has published in prestigious journals such as JAMA, SHILAP Revista de lepidopterología and PEDIATRICS.

In The Last Decade

Katherine E. Fleming-Dutra

120 papers receiving 5.0k citations

Hit Papers

Preliminary Estimates of the Prevalence of Selected ... 2016 2026 2019 2022 2020 2016 2022 2023 2023 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 — United States, February 12–March 28, 2020
    2020 992 citations Katherine E. Fleming-Dutra, Tamara Pilishvili et al. MMWR Morbidity and Mortality Weekly Report profile →
  2. Core Elements of Outpatient Antibiotic Stewardship
    2016 425 citations Katherine E. Fleming-Dutra, Lauri A. Hicks et al. profile →
  3. Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants
    2022 403 citations Emma K. Accorsi, Amadea Britton et al. profile →
  4. Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023
    2023 171 citations Jefferson M. Jones, Katherine E. Fleming-Dutra et al. MMWR Morbidity and Mortality Weekly Report profile →
  5. Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus–Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023
    2023 144 citations Katherine E. Fleming-Dutra, Jefferson M. Jones et al. MMWR Morbidity and Mortality Weekly Report profile →
  6. Early Estimates of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Attributable to Co-Circulating Omicron Variants Among Immunocompetent Adults — Increasing Community Access to Testing Program, United States, September 2023–January 2024
    2024 80 citations Ruth Link‐Gelles, Allison Avrich Ciesla et al. MMWR Morbidity and Mortality Weekly Report profile →
  7. Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5– and XBB/XBB.1.5–Related Sublineages Among Immunocompetent Adults — Increasing Community Access to Testing Program, United States, December 2022–January 2023
    2023 76 citations Ruth Link‐Gelles, Allison Avrich Ciesla et al. MMWR Morbidity and Mortality Weekly Report profile →
  8. Use of Respiratory Syncytial Virus Vaccines in Adults Aged ≥60 Years: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2024
    2024 67 citations Amadea Britton, Lauren E. Roper et al. MMWR Morbidity and Mortality Weekly Report profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katherine E. Fleming-Dutra United States 35 2.0k 1.9k 1.1k 662 535 123 5.3k
Susan Hopkins United Kingdom 39 3.3k 1.7× 1.8k 1.0× 1.4k 1.2× 881 1.3× 706 1.3× 198 7.0k
Marc Aerts Belgium 41 1.1k 0.6× 1.8k 1.0× 404 0.4× 424 0.6× 357 0.7× 227 6.7k
André Charlett United Kingdom 51 3.3k 1.7× 2.6k 1.4× 340 0.3× 584 0.9× 316 0.6× 275 9.7k
Dominik Mertz Canada 27 1.4k 0.7× 1.6k 0.8× 397 0.4× 266 0.4× 242 0.5× 120 5.0k
Mary‐Louise McLaws Australia 43 3.3k 1.7× 1.5k 0.8× 526 0.5× 580 0.9× 426 0.8× 181 7.0k
Tim Eckmanns Germany 39 1.8k 0.9× 1.8k 0.9× 859 0.8× 444 0.7× 251 0.5× 196 5.4k
Graham Cooke United Kingdom 47 4.1k 2.1× 4.4k 2.4× 623 0.5× 464 0.7× 153 0.3× 188 9.1k
James Baggs United States 40 2.8k 1.4× 2.0k 1.1× 496 0.4× 260 0.4× 944 1.8× 135 5.9k
Carlo Giaquinto Italy 52 5.4k 2.7× 2.6k 1.4× 362 0.3× 664 1.0× 385 0.7× 360 9.5k
Ann Van den Bruel United Kingdom 36 1.5k 0.8× 1.4k 0.7× 304 0.3× 594 0.9× 93 0.2× 136 5.2k

Countries citing papers authored by Katherine E. Fleming-Dutra

Since Specialization
Citations

This map shows the geographic impact of Katherine E. Fleming-Dutra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katherine E. Fleming-Dutra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katherine E. Fleming-Dutra more than expected).

Fields of papers citing papers by Katherine E. Fleming-Dutra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katherine E. Fleming-Dutra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katherine E. Fleming-Dutra. The network helps show where Katherine E. Fleming-Dutra may publish in the future.

Co-authorship network of co-authors of Katherine E. Fleming-Dutra

This figure shows the co-authorship network connecting the top 25 collaborators of Katherine E. Fleming-Dutra. A scholar is included among the top collaborators of Katherine E. Fleming-Dutra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katherine E. Fleming-Dutra. Katherine E. Fleming-Dutra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hutton, David W., Lisa A. Prosser, Angela Rose, et al.. (2024). Cost-Effectiveness of Maternal Vaccination to Prevent Respiratory Syncytial Virus Illness. PEDIATRICS. 154(6). 10 indexed citations
2.
3.
Panagiotakopoulos, Lakshmi, Monica Godfrey, Danielle Moulia, et al.. (2024). Use of an Additional Updated 2023–2024 COVID-19 Vaccine Dose for Adults Aged ≥65 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024. MMWR Morbidity and Mortality Weekly Report. 73(16). 377–381. 18 indexed citations
4.
Panagiotakopoulos, Lakshmi, Danielle Moulia, Monica Godfrey, et al.. (2024). Use of COVID-19 Vaccines for Persons Aged ≥6 Months: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024–2025. MMWR Morbidity and Mortality Weekly Report. 73(37). 819–824. 29 indexed citations
5.
Fleming-Dutra, Katherine E., Jefferson M. Jones, Lauren E. Roper, et al.. (2023). Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus–Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023. MMWR Morbidity and Mortality Weekly Report. 72(41). 1115–1122. 144 indexed citations breakdown →
6.
Fleming-Dutra, Katherine E., Allison Avrich Ciesla, Lauren E. Roper, et al.. (2023). Preliminary Estimates of Effectiveness of Monovalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection Among Children Aged 3–5 Years — Increasing Community Access to Testing Program, United States, July 2022–February 2023. MMWR Morbidity and Mortality Weekly Report. 72(7). 177–182. 11 indexed citations
7.
8.
Link‐Gelles, Ruth, Amadea Britton, & Katherine E. Fleming-Dutra. (2023). Building the U.S. COVID-19 vaccine effectiveness program: Past successes and future directions. Vaccine. 42. 125492–125492. 6 indexed citations
9.
Tsay, Sharon, Danielle Palms, Laura King, et al.. (2023). Regional Variation in Outpatient Antibiotic Prescribing for Acute Respiratory Tract Infections in a Commercially Insured Population, United States, 2017. Open Forum Infectious Diseases. 10(2). ofac584–ofac584. 9 indexed citations
10.
Link‐Gelles, Ruth, Allison Avrich Ciesla, Lauren E. Roper, et al.. (2023). Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5– and XBB/XBB.1.5–Related Sublineages Among Immunocompetent Adults — Increasing Community Access to Testing Program, United States, December 2022–January 2023. MMWR Morbidity and Mortality Weekly Report. 72(5). 119–124. 76 indexed citations breakdown →
11.
Gidengil, Courtney A., Jefferson M. Jones, Katherine E. Fleming-Dutra, et al.. (2023). 1633. Willingness to receive maternal RSV vaccine and infant monoclonal RSV antibody. Open Forum Infectious Diseases. 10(Supplement_2). 2 indexed citations
12.
Mohr, Nicholas M., Ian D. Plumb, Karisa K. Harland, et al.. (2023). Presence of symptoms 6 weeks after COVID-19 among vaccinated and unvaccinated US healthcare personnel: a prospective cohort study. BMJ Open. 13(2). e063141–e063141. 17 indexed citations
13.
King, Laura, et al.. (2021). Changes in outpatient antibiotic prescribing for acute respiratory illnesses, 2011 to 2018. SHILAP Revista de lepidopterología. 1(1). 1–8. 13 indexed citations
14.
Lewnard, Joseph A., Laura King, Katherine E. Fleming-Dutra, Ruth Link‐Gelles, & Chris Van Beneden. (2020). Incidence of Pharyngitis, Sinusitis, Acute Otitis Media, and Outpatient Antibiotic Prescribing Preventable by Vaccination Against Group A Streptococcus in the United States. Clinical Infectious Diseases. 73(1). e47–e58. 18 indexed citations
15.
King, Laura, et al.. (2020). Unnecessary antibiotic prescribing in pediatric ambulatory care visits for bronchitis and bronchiolitis in the United States, 2006–2015. Infection Control and Hospital Epidemiology. 42(5). 612–615. 5 indexed citations
16.
King, Laura, Katherine E. Fleming-Dutra, & Lauri A. Hicks. (2018). Advances in optimizing the prescription of antibiotics in outpatient settings. BMJ. 363. k3047–k3047. 86 indexed citations
17.
Gruchalla, Kenny, et al.. (2016). CITY SCALE MODELING WITH OPENSTUDIO. Proceedings of SimBuild. 6(1). 8 indexed citations
18.
Fleming-Dutra, Katherine E., Laura Conklin, Jennifer D. Loo, et al.. (2013). Systematic Review of the Effect of Pneumococcal Conjugate Vaccine Dosing Schedules on Vaccine-type Nasopharyngeal Carriage. The Pediatric Infectious Disease Journal. 33(Supplement 2). S152–S160. 77 indexed citations
19.
Fleming-Dutra, Katherine E., Jingnan Mao, & Julie C. Leonard. (2013). Acute Care Costs in Overweight Children: A Pediatric Urban Cohort Study. Childhood Obesity. 9(4). 338–345. 14 indexed citations
20.
Loo, Jennifer D., Laura Conklin, Maria Deloria Knoll, et al.. (2013). Methods for a Systematic Review of Pneumococcal Conjugate Vaccine Dosing Schedules. The Pediatric Infectious Disease Journal. 33(Supplement 2). S182–S187. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susan Hopkins Breakdown of academic impact, for papers by Marc Aerts Breakdown of academic impact, for papers by André Charlett Breakdown of academic impact, for papers by Dominik Mertz Breakdown of academic impact, for papers by Mary‐Louise McLaws Breakdown of academic impact, for papers by Tim Eckmanns Breakdown of academic impact, for papers by Graham Cooke Breakdown of academic impact, for papers by James Baggs Breakdown of academic impact, for papers by Carlo Giaquinto Breakdown of academic impact, for papers by Ann Van den Bruel
Rankless by CCL
2026